Studies how copper and zinc levels relate to outcomes in kidney failure patients
Observes how the copper to zinc ratio relates to outcomes in adults with kidney failure.
Plain-language title generated from the registry record
Registry title: Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome
Key facts
- Where
- Minya, EgyptSee the site
Where in Egypt
- Nephrology and urology hospital, Minia unersity hospital, Faculty of medicine, Minia universityMinya, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Minia University
- Trial code
- NCT07109778
- Record updated
- 7 August 2025
- Original description
The goal of this observational clinical trial is to Study the impact of copper to zinc ratio on the outcome of ESRD patientsRead full original descriptionShow less
Impact of Copper to Zinc Ratio on Outcome of End Stage Renal Disease Patients
The goal of this observational clinical trial is to Study the impact of copper to zinc ratio on the outcome of ESRD patients
Inclusion: ESRD patients including those on maintenance HD.
Exclusion: Acute kidney injury or rapidly progressive glomerulonephritis, acute infections or active inflammatory conditions as sepsis and autoimmune diseases, liver cirrhosis (Child-Pugh Class B or C), gastrointestinal disorders as inflammatory bowel disease, malabsorption, history of organ transplantation excluding kidney transplantation who may be included in a separate analysis if sufficient numbers are recruited, receiving total parenteral nutrition, Cu or Zn metabolism disorders as Wilson's disease, vitamin complex supplementation or antioxidants within the past 6 months, recent hospitalization within the past 3 months, recent surgery within 3 months, recent blood transfusion < 3 months, Pregnancy or lactation, Malignancy.